Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
17.58
-0.96 (-5.18%)
At close: Nov 20, 2026, 4:00 PM EST
18.00
+0.42 (2.39%)
After-hours: Nov 20, 2026, 7:30 PM EST
Caris Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 665.32 | 796.27 | 63.95 | 56.4 | 107.19 |
Short-Term Investments | 102.06 | 2.3 | 2.2 | 65.18 | 302.43 |
Cash & Short-Term Investments | 767.38 | 798.57 | 66.15 | 121.59 | 409.62 |
Cash Growth | 1.57% | 1107.19% | -45.59% | -70.32% | - |
Receivables | 133.32 | 112.14 | 88.24 | 55.3 | 40.23 |
Inventory | 138.37 | 63.63 | 39.57 | 49 | 46.96 |
Prepaid Expenses | 23.28 | 19.59 | 13.56 | 11.77 | 13.36 |
Restricted Cash | - | 1.53 | 1.49 | 3.61 | 3.95 |
Other Current Assets | 4.91 | 2.36 | 6.71 | 1.36 | 1.93 |
Total Current Assets | 1,067 | 997.8 | 215.73 | 242.61 | 516.04 |
Property, Plant & Equipment | 102.3 | 103.02 | 102.77 | 147.51 | 179.19 |
Goodwill | 19.34 | 19.34 | 19.34 | 19.34 | 19.34 |
Other Long-Term Assets | 66.72 | 5.5 | 5.89 | 3.43 | 2.85 |
Total Assets | 1,256 | 1,126 | 343.73 | 412.9 | 717.42 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 63.84 | 39.21 | 27.79 | 26.68 | 27.27 |
Accrued Expenses | 70.36 | 56.92 | 63.99 | 55.68 | 51.11 |
Current Portion of Long-Term Debt | 0.09 | - | 60 | - | 52.04 |
Current Portion of Leases | 6.29 | 6.53 | 6.17 | 6.59 | 5.05 |
Current Unearned Revenue | 18.37 | 24.49 | 7.47 | 5.68 | 1.43 |
Other Current Liabilities | - | - | - | 0.51 | - |
Total Current Liabilities | 158.95 | 127.15 | 165.42 | 95.14 | 136.91 |
Long-Term Debt | 393.18 | 378.45 | 319.2 | 166.11 | 169.09 |
Long-Term Leases | 63.47 | 42.71 | 38.89 | 44.41 | 44.69 |
Other Long-Term Liabilities | - | 0.05 | 97.41 | 126.91 | 114.68 |
Total Liabilities | 616.14 | 548.36 | 620.92 | 432.57 | 465.36 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0.29 | 0.28 | 0.04 | 0.04 | 0.14 |
Additional Paid-In Capital | 3,174 | 3,142 | - | - | - |
Retained Earnings | -2,535 | -2,549 | -2,472 | -2,119 | -1,679 |
Treasury Stock | - | -16.9 | -0.33 | -0.33 | -0.33 |
Comprehensive Income & Other | -0.11 | 0.94 | -26.25 | -25.48 | -23.27 |
Total Common Equity | 639.48 | 577.31 | -2,499 | -2,145 | -1,702 |
Shareholders' Equity | 639.48 | 577.31 | -277.19 | -19.67 | 252.06 |
Total Liabilities & Equity | 1,256 | 1,126 | 343.73 | 412.9 | 717.42 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 463.02 | 427.69 | 424.26 | 217.11 | 270.87 |
Net Cash (Debt) | 304.36 | 370.88 | -358.11 | -95.52 | 138.75 |
Net Cash Growth | -7.42% | - | - | - | - |
Net Cash Per Share | 1.04 | 2.22 | -10.09 | -2.73 | 4.16 |
Filing Date Shares Outstanding | 286.78 | 282.58 | 277.93 | 35.11 | 33.37 |
Total Common Shares Outstanding | 286.72 | 282.53 | 36.5 | 35.11 | 33.37 |
Working Capital | 908.32 | 870.66 | 50.31 | 147.47 | 379.14 |
Book Value Per Share | 2.23 | 2.04 | -68.45 | -61.08 | -51.01 |
Tangible Book Value | 620.14 | 557.96 | -2,518 | -2,164 | -1,721 |
Tangible Book Value Per Share | 2.16 | 1.97 | -68.98 | -61.63 | -51.59 |
Machinery | 243.71 | 212.44 | 207.47 | 224.65 | 210.05 |
Leasehold Improvements | 67.81 | 63.81 | 63.04 | 66.58 | 63.1 |